Skip to content
Carbetapentane
Carbetapentane is a small molecule pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
SARS-CoV-2 Interaction
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
respiratory tract diseasesD012140
signs and symptoms pathological conditionsD013568
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
coughHP_0012735D003371R05
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
R: Respiratory system drugs
R05: Cough and cold preparations
R05D: Cough suppressants, excl. combinations with expectorants
R05DB: Other cough suppressants in atc
R05DB05: Pentoxyverine
HCPCS
No data
Clinical
Clinical Trials
123 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
SchizophreniaD012559EFO_0000692F202617281263
Bipolar disorderD001714EFO_0000289F30.921411633
Psychotic disordersD011618F20.813619431
DepressionD003863F33.91124
Major depressive disorderD003865EFO_0003761F222114
Anxiety disordersD001008EFO_0006788F41.1123
DeliriumD003693R41.01113
ManiaD000087122F30213
Schizophrenia spectrum and other psychotic disordersD01996722
Mood disordersD019964EFO_0004247F30-F391112
Show 6 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
DementiaD003704F0311
Psychophysiologic disordersD011602F45.911
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Social phobiaD000072861EFO_1001917F40.111
Cognition disordersD00307211
Conduct disorderD019955EFO_0004216F9111
Attention deficit and disruptive behavior disordersD019958HP_0010865F91.311
Borderline personality disorderD001883HP_0012076F60.311
Autistic disorderD001321EFO_0003758F84.011
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients33
Opioid-related disordersD009293EFO_0005611F1111
Cardiovascular diseasesD002318EFO_0000319I9811
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Psychomotor agitationD01159522
HyperglycemiaD006943HP_0003074R73.922
Type 2 diabetes mellitusD003924EFO_0001360E1122
HyperlipidemiasD006949EFO_0003774E78.511
Obsessive-compulsive disorderD009771EFO_0004242F4211
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameCARBETAPENTANE
INNpentoxyverine
Description
1-phenyl-1-cyclopentanecarboxylic acid 2-[2-(diethylamino)ethoxy]ethyl ester is a member of benzenes.
Classification
Small molecule
Drug class
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CCN(CC)CCOCCOC(=O)C1(c2ccccc2)CCCC1
Identifiers
PDB
CAS-ID77-23-6
RxCUI20217
ChEMBL IDCHEMBL73234
ChEBI ID
PubChem CID2562
DrugBankDB11186
UNII ID32C726X12W (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 131 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
13,882 adverse events reported
View more details